Navigation Links
Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
Date:5/13/2009

THOUSAND OAKS, Calif., May 13 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will present at the Deutsche Bank 34th Annual Healthcare Conference on Monday, May 18, 2009 at the InterContinental, Boston, Mass., beginning at 9:20 a.m. Eastern Time. Chairman and Chief Executive Officer Kevin Sharer will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    Arvind Sood, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
3. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
4. Amgen to Present at the Barclays Capital Global Healthcare Conference
5. Amgen Announces Webcast of 2009 First Quarter Financial Results
6. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
7. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
8. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
9. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
10. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... research group of Dr. Franois Robert, a researcher at ... collaboration with the team of Dr. Daniel Durocher (Samuel ... technical breakthrough: they mapped all the fragile sites of ... . The method used by the researchers can be ... today in the scientific journal Nature Structural and ...
(Date:2/9/2010)... launched the nation,s first comprehensive research and training ... FBI has called "the crime of the 21st ... to food additives to auto parts- accounts for ... and has a major impact on health and ... Terrorist and other organized crime groups use proceeds ...
(Date:2/9/2010)... may be more effective in persuading young women to ... same issue, according to a new study. , Researchers ... about a teen pregnancy felt more vulnerable two weeks ... support for using birth control. , However, those who ... teen pregnancies were unmoved, and had no change in ...
(Date:2/9/2010)... Rockville, MD -- The first results from a ... Sub-Saharan African countries reveal that a high percentage ... substandard quality and thus may contribute to the ... , the most virulent form of malaria. The ... of Medicines (PQM) Program, a USAID-funded program implemented ...
(Date:2/9/2010)... YORK , Feb. 9 The ... Glover Blackwell : ,, "Reversing the childhood obesity epidemic ... Michelle Obama demonstrated today. ,, "As ... attend schools loaded with chips and soda -- and ... children, however, that bleak food landscape extends far beyond ...
Breaking Medicine News(10 mins):Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3
... of Bone and Mineral Research study by Indiana University-Purdue University ... fractures later in life. The study is now available in ... in a print edition in 2007. ,'Our ... of fractures later in life, and the old exercise adage ...
... to a International Labor Organization (ILO) report issued on Dec ... unable to work partially or fully due to// HIV and ... ILO added that the virus had a crippling effect on ... the virus has among children has threatened the future working ...
... Allergo Sorbent Test’ (RAST) machine, has been designed at ... the source allergen. ,An allergy is regarded ... it perceives as unsuitable. Hay fever, migraine, asthma, allergic ... the common allergic responses. ,At a press ...
... Scientists at Kings College, London have developed a new drug ... concept on which the drug is based on is that ... is prevented, thus sperms are not propelled out of the ... the control of schizophrenia and blood pressure, to which researchers ...
... implanted devices in their hearts face risks. The devices called ... allow an easy passage of// blood. It is inserted into ... that are coated with drugs are more liable to suffer ... times greater when compared to patients who use stents that ...
... with support from National Institute of Health and ... (ICMR), conducts// Sentinel Surveillance every year among high-risk ... the results of HIV prevalence in different population ... prevalence states where HIV prevalence among antenatal mothers ...
Other Medicine News:Health News:Exercise In Childhood Provides Lifelong Benefits 2Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2Health News:Using Heart Stents Tends to Form More Clots 2
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
(Date:2/9/2010)... , February 9 Hoya Corporation ... December 31, 2009 .,Net sales were 106.8 billion ... 112.7,billion yen in the same period last ... 13.8% increase from 16.6 billion yen in ... orders and productivity. Compared to the second,quarter ended ...
(Date:2/9/2010)... , Feb. 9 Sanofi-aventis (EURONEXT: ... that it has successfully completed its tender offer for ... ( CHTT).   ,, The tender offer and withdrawal ... time, on February 8, 2010 .  The ... as of the expiration time, approximately 18,611,072 shares of ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Hoya Announces Third Quarter Financial Results 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5How do we fund plant breeding 3F 10551 1How do we fund plant breeding 3F 10551 2How do we fund plant breeding 3F 10551 3Cranberries Provide Eight Hour Health Protection 60228 1Cranberries Provide Eight Hour Health Protection 60228 2Cranberries Provide Eight Hour Health Protection 60228 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
... high-throughput immunoassay system built around the many ... the important addition of Logic Driven Incubation ... designed for optimal performance with the fastest ... assays such as the cardiac biomarkers and ...
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
IRMA kit for detection of the cardiac marker Myoglobin...
Medicine Products: